Product


BreastSeq: Brest and Ovarian Cancer genetic test
The HC-Gen Test analyzes the 19 major susceptibility genes for hereditary breast cancer. The estimated risk to suffer breast cancer is directly related to mutations in these genes.
The Next-generation sequencing or massive sequencing offers the possibility of analyzing simultaneously ALL these genes related to hereditary breast cancer, for mutations, and not just the two main genes (BRCA1 and BRCA2) as is being done routinely in a while.
 
Cancer is one of the leading causes of death by disease in the world. Approximately 5% to 10% of all cancers are hereditary origin. This means that changes (or mutations) in specific genes responsible for the disease are transmitted from parents to children. People who carry in their DNA such changes are more likely to develop cancer during their lifetime.
The latest knowledge and technology allows us to analyze the DNA of multiple genes related to hereditary cancer.
The HC-Gen Test is the ideal tool to identify genetic variations related to cancer in your patients. It is a genetic test that allows the simultaneous detection of mutations in ALL the genes associated with hereditary cancer syndromes using ultrasequencing DNA techniques.
 
 
Related links:
 
 
Permalink  
 
Developed by Web4Bio